Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106447893 | 10644789 | 3 | F | 20100110 | 20160928 | 20141211 | 20160930 | EXP | BE-ROCHE-1504541 | ROCHE | 38.00 | YR | F | Y | 0.00000 | 20160930 | CN | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106447893 | 10644789 | 1 | PS | TAMIFLU | OSELTAMIVIR PHOSPHATE | 1 | Oral | Y | 21246 | ORAL SUSPENSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106447893 | 10644789 | 1 | Influenza |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106447893 | 10644789 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106447893 | 10644789 | Maternal exposure during pregnancy | |
| 106447893 | 10644789 | Pneumonia aspiration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106447893 | 10644789 | 1 | 20100110 | 20100114 | 0 |